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Abstract
End-of-life decision-making in patients with dementia is a complex topic. Belgium 
and the Netherlands have been at the forefront of legislative advancement and pro-
gressive societal changes concerning the perspectives toward physician-assisted 
death (PAD). Careful consideration of clinical and social aspects is essential during 
the end-of-life decision-making process in patients with dementia. Geriatric assent 
provides the physician, the patient and his family the opportunity to end life with 
dignity. Unbearable suffering, decisional competence, and awareness of memory 
deficits are among the clinical considerations that physicians should incorporate dur-
ing the end-of-life decision-making process. However, as other societies introduce 
legislature granting the right of PAD, new social determinants should be consid-
ered; Mexico City is an example. Current perspectives regarding advance euthanasia 
directives (AED) and PAD in patients with dementia are evolving. A new perspec-
tive that hinges on the role of the family and geriatric assent should help culturally 
heterogeneous societies in the transition of their public health care policies regard-
ing end-of-life choices.
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1 Introduction
It was the best of times, it was the worst of times, it was the age of wisdom, it was 
the age of foolishness, it was the epoch of belief, it was the epoch of incredulity, it 
was the season of Light, it was the season of Darkness, it was the spring of hope, 
it was the winter of despair, we had everything before us, we had nothing before 
us, we were all going direct to Heaven, we were all going direct the other way—in 
short, the period was so far like the present period, that some of its noisiest authori-
ties insisted on its being received, for good or for evil, in the superlative degree of 
comparison only. Charles Dickens, A Tale of Two Cities.
1.1  Definitions and legal due care criteria for PAD
Physician assistance in dying or physician-assisted death (PAD) refers to physician-
assisted suicide (PAS) and euthanasia (Dresser 2017). PAS is when a physician, 
upon patient request, provides a self-administered lethal medication, while meeting 
the legal due care criteria for PAD (Haan 2002). In contrast, euthanasia alludes to 
the administration of a lethal medication by a physician at the request of a patient 
(Haan 2002). While both euthanasia and PAS are legal in the Netherlands, Luxem-
burg, and Canada, euthanasia is the only legal form of PAD in Belgium and Colom-
bia (Emanuel et al. 2016), while Victoria, Australia, permits PAS and euthanasia is 
also allowed for people for whom PAS is not viable because they cannot take the 
medications themselves to end their life. Furthermore, PAS is the only legal form of 
PAD, which is referred to as ‘Aid in dying’, in Oregon, Washington, Montana, Ver-
mont, California (Emanuel et al. 2016), Colorado, New Jersey, Maine, Hawaii and 
Washington D.C.; while in Switzerland assisted suicide in a non-medical context is 
allowed. Since most countries have adopted a version similar to the Dutch due care 
criteria, we have opted to discuss these. The due care criteria for PAD in the Dutch 
Euthanasia Act are: (1) the attending physician has come to the conviction that the 
request from the patient is voluntary and well-considered; (2) the attending physi-
cian has come to the conviction that the suffering of the patient is unbearable and 
without prospect of improvement; (3) the physician has informed the patient about 
his situation and prospects; (4) the patient and physician must concur that there 
are no more reasonable alternatives to relieve suffering; (5) the physician has con-
sulted an independent physician; (6) the physician has terminated the patient’s life 
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or assisted with suicide with due medical care and attention (Beaufort and Vathorst 
2016; RTE Annual Reports 2004; Snijdewind et  al. 2015). For an abridged legal 
framework of physician-assisted death, we refer the reader to the Supplementary 
Material.
In Mexico, PAD is illegal. Euthanasia is considered a homicide and carries a 
10-year to a 14-year prison sentence, while PAS is classified as an assisted homicide 
and carries a 2-year to a 5-year prison sentence (Río et al. 2017). In 2008, Mexico 
City approved a law (i.e. “Ley de Voluntad Anticipada” or Advanced Directives 
Law) that legalizes advance health care directives (AHD), allowing citizens to estab-
lish a medical directive regarding the continuation or termination of treatments that 
extend life under conditions that the subject deems not worth living (Secretaría de 
Salud de la Ciudad de México 2008). This law absolves the physician who discon-
tinues the treatments aimed at extending the life of any legal prosecution. Approxi-
mately half (i.e. 15 out of the 31) of the states in Mexico have an AHD law similar 
to that of the country’s capital (Río et al. 2017). Along with the AHD law, the Gen-
eral Health Law (i.e. “Ley General de Salud”) establishes that patients with terminal 
illnesses must be offered palliative care measures (Salud 2007). Among the pallia-
tive care options, the patient may receive palliative sedation. Even though PAD is 
illegal, the patient has the right to request irreversible deep sedation; meanwhile, the 
physician is protected by law (Río et al. 2017). For a thorough analysis of the cul-
tural and political attitudes, as well as current and future perspectives toward PAD 
in Mexico we refer the reader to the text by del Río (Río et al. 2017) and the book 
by González-Huerta et  al. (2017).1 Nevertheless, due to poverty, just a small por-
tion of inhabitants can receive palliative options of good quality. As of January 30, 
2017, the constitution of Mexico City under article 11 incorporates the right of per-
sonal auto-determination, and the right to live with dignity; which in its own right 
includes the right to pursue death with dignity (Asamblea Constituyente Ciudad de 
México 2017).
1.2  Advance euthanasia directive and geriatric assent (vide infra)
Euthanasia and PAS are complex topics that promote debate in both public opin-
ion and the medical profession around the world. In traditional-religious oriented 
cultures people consider religion, family and deference to authority as important 
values; conversely, they reject divorce, abortion, suicide, and euthanasia (Heide 
2013). The strategy for the evaluation regarding decision-making capacity can be 
simplified into five steps according to Moberg and Rick (Moberg and Rick 2008), 
(1) clarification of the referral question and determination of the patient’s compe-
tence, (2) planning, cultural assessment and ethical considerations according to the 
topic, (3) assessment, (4) communication of the results, and (5) recommendation of 
any additional evaluations or interventions (Moberg and Rick 2008). Adding another 
1 Decisiones médicas sobre el final de la vida en pacientes con enfermedad de Alzheimer. Un abordaje 
interdisciplinario: Fontamara (2017), p. 4.
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level of complexity to this debate is the opinion and influence that religion plays 
in public policymaking in Latin America (Río et  al. 2017). While public opinion 
polls in the United States suggest a decline in support regarding euthanasia from a 
peak of 75% in 2005 to 64% in 2012, in Central and Eastern Europe there has been 
no increase and even a decrease in acceptance, also due to religious movements; 
however, in Western Europe support for euthanasia increased (Emanuel et al. 2016). 
The perspectives of the general population, surveyed to date, in Mexico (i.e. adults 
18–49 years of age, middle or high income and Catholics) regarding their accept-
ance of euthanasia oscillates between 60 and 65% (Río et al. 2017; Muñoz 2005). 
Acceptance of PAD from the general population and the medical profession has 
been on the rise (Río et al. 2017). Complete acceptance of PAD hinges on raising 
awareness and educating both the public as well as the medical profession; nonethe-
less, since more than fifty million people in Mexico live in poverty, topics such as 
euthanasia are not part of public discourse.
Until now, requests for advance euthanasia directives (AED) must describe the 
point at which death should occur (Río et al. 2017); however, this decision as diffi-
cult as it might be, must be discussed between the patient and the physician. The due 
care criteria also apply when the patient formulates an AED (RTE Annual Reports 
2004). In the Netherlands although not a legal requirement, it is advised that the 
directive be updated on regular intervals and should define as clearly as possible the 
circumstances in which PAD is the preferred option (RTE Annual Reports 2004). 
Furthermore, the committees recommend the physician to record details about the 
general discussion regarding the patient’s end-of-life wishes to provide solid argu-
ments regarding the joint PAD decision-making process (RTE Annual Reports 
2004). The clinician must consider that by the time a patient meets his/her pre-estab-
lished AED criteria they probably do not remember their earlier request and may 
show no signs of suffering (Dresser 2017). In this regard, Belgian law stipulates that 
the patients who requested an AED, in compos mentis and the presence of two wit-
nesses, must be no longer conscious (Landry et al. 2015) and the AED is only appli-
cable in cases of unconsciousness. In this context, unconsciousness is a complex 
clinical term and an even more intricate neurobiological phenomenon. Unconscious-
ness could refer to the clinical state of decreased wakefulness (i.e. decreased brain 
stem function), decreased awareness of the patient’s surroundings (i.e. decreased 
cortico-thalamic network activation) or even lack of awareness of memory deficits 
(i.e. anosognosia, decreased activation of default mode network and middle cortical 
structures).2 To avoid future problems the Dutch RTEs advise the physicians who 
are discussing euthanasia with their patients to draw up a written directive in good 
time; furthermore, the RTEs recommend that the physicians discuss the content and 
implications of such directive with the patient, advising that “the more specific the 
euthanasia directive, the firmer the basis for the attending physician’s decision and 
the committee’s assessment (RTE Annual Reports 2004). Furthermore, although not 
a legal requirement, the RTE suggests that the directive should be handwritten by 
2 For an in-depth take on the neural correlates of disorders of consciousness we refer the reader to the 
text by Di Perri et al. (2014) and Mondragon et al. (2019) for anosognosia in AD.
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the patient, for clarification purposes, thus describing of the circumstances in his 
own words.
Advance euthanasia directives and PAD requests hinge on an intimate patient-
physician relationship, thus geriatric assent can provide an adequate basis for a 
shared decision process. Patients with dementia aren’t, usually, asked about their 
opinion in the informed consent process. Although, the patient might have limited 
decision-making capacity, nonetheless, they are still capable of expressing their pref-
erences. Geriatric assent refers to the process of considering the preferences of an 
older and cognitively impaired patient in decision-making; furthermore, by knowing 
the patients’ preferences, physicians that practice geriatric assent, protect patients’ 
autonomy and the decisions that will be made about their own life and health (Moli-
nari et  al. 2004). Geriatric assent is a process that balances the limited cognitive 
capacities of a cognitively impaired patient with the priorities of the family mem-
bers to maintain involvement in health care decisions (Molinari et  al. 2006). The 
four step-process for promoting geriatric assent include: (1) identifying the patient’s 
long-standing values and preferences; (2) assessing plans of care in terms of biopsy-
chosocial safety and independence along with the patient’s values and preferences; 
(3) protecting remaining autonomy; and (4) cultivating the professional virtues of 
steadiness, self-effacement, and self-sacrifice when making decisions that risk the 
patient’s future health and safety (Coverdale et  al. 2006). Geriatric assent is best 
accomplished with a multidisciplinary team that encourages family involvement and 
that understands the patient’s health-related cultural context (Molinari et al. 2006). 
Geriatric assent provides the physician, the patient, and his family the opportunity 
to end life with dignity. Death with dignity should always be the end result of PAD; 
taking into consideration the patient’s psychological needs and emotional state, the 
patient’s susceptibility for depression and demoralization, the patient’s competence 
and ability to process information, and the caregivers’ influence and psychological 
situation (Cohen-Almagor 2016).
1.3  Objectives
The primary aim of this article is to build upon two bioethical perspectives (i.e. 
Flemish and Dutch versus Mexican perspective) for clinical decision-making regard-
ing physician-assisted death for patients with dementia. To achieve this we provide 
contrasting, but supplementary bioethical perspectives regarding the decision-mak-
ing process in PAD for patients with dementia from Belgium, the Netherlands, and 
Mexico. We will engage in a dialectic exercise, where the contrasting perspectives 
on PAD for patients with dementia will serve as the platform to discuss the bioethi-
cal attitudes and clinical approaches to assist the end-of-life decision-making pro-
cess. A secondary aim of this work is to serve as an update of the recent changes 
regarding the outlook of end-of-life perspectives toward PAD and AED in patients 
with dementia, as well as to propose a new perspective that focuses on geriatric 
assent and the role of the family in societies that have a family-physician medical 
consensus approach to end-of-life decision making.
 J. D. Mondragón et al.
1 3
2  Bioethical implications of end‑of‑life decision‑making in dementia
End-of-life decision-making in patients with dementia is a complex topic. Careful 
consideration of clinical and social aspects is essential in the end-of-life decision-
making process in patients with dementia. Unbearable suffering and decisional com-
petence are two clinical topics that have emerged as part of the discussion when 
evaluating the due care process in cases reporting PAD in dementia in RTE annual 
reports during the last 5 years. Awareness of memory deficits has posed a serious 
challenge for clinicians attempting to assess the validity of an AED. As more socie-
ties are introducing laws legalizing PAD, more challenges arise. The challenges that 
Mexico City will face in the upcoming years will provide further insight into the 
complex relationship between medical issues that have ample social consequences. 
In the next section, the authors will present current perspectives and a new per-
spective that hinges on the role of the family and geriatric assent. For perspectives 
opposing PAD and AED in patients with dementia, current perspectives of PAD and 
palliative care for patients with dementia in Mexico, and the PAD cases involving 
patients suffering from dementia in the annual Dutch review committee reports, we 
refer the reader to the supplementary material.
2.1  End‑of‑life outcomes in patients with dementia in Belgium 
and the Netherlands
Belgium and the Netherlands have been at the forefront of legislative advancement 
and progressive societal changes concerning the perspectives toward PAD. The first 
case of PAD for a patient with dementia reported by the Dutch RTE Annual Report 
was in 2004 and the first case with advanced dementia was notified in 2011. Data 
on PAD among patients with dementia in the Netherlands indicates an increase of 
49 cases in 2009 to 97 cases in 2013 and 84 in 2014 (Beaufort and Vathorst 2016). 
In comparison, the proportion of PAD reported cases with dementia in Belgium 
has gradually increased accounting for 0.25% (5 cases) from 2002 to 2007 reaching 
0.83% (57 cases) from 2008 to 2013 (Dierickx et al. 2017).
The Dutch regional committees began to specifically report PAD in patients with 
dementia from 2009; reporting only seven cases from 2002 to 2006, 86 from 2007 
to 2011, 470 from 2012 to 2016, and 169 cases in 2017 (i.e. 166 early dementia and 
3 advanced or very advanced stage of dementia). All the attending physicians, when 
notifying a PAD involving a patient with dementia, acted in accordance with the laws 
of due care from 2002 to 2011; however, from 2012 to 2016, three cases involving 
dementia patients did not comply with the due care criteria. The three cases involved 
patients with an advanced stage of Alzheimer’s disease (AD). Requests for PAD, for 
all diseases, are granted by physicians at a rate of 25–45% in the Netherlands (Sni-
jdewind et al. 2015; Jansen-van der Weide et al. 2005; Onwuteaka-Philipsen et al. 
2012; Maas et al. 1996). Among the five medical conditions (i.e. somatic, psycho-
logical, somatic and psychological, cognitive decline, and tired of living) reported 
where there was a request for PAD, cognitive decline had the highest rate of granted 
requests at 37.5% compared to an overall granted rate of 25.1% for the five medical 
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conditions (Snijdewind et al. 2015). Additionally, requests for PAD of patients with 
cognitive decline were the second-lowest with 35.7%; meanwhile, somatic medical 
conditions had the lowest rejection rate, with 34% and an overall rejection rate of 
46.5% (Snijdewind et al. 2015). Analogously, a Belgian study found that 48% of the 
request for euthanasia in 100 consecutive psychiatric patients requesting euthana-
sia was granted; although the study did not include dementia patients, 90% of the 
patients had more than one psychiatric disorder, with depression (i.e. 58%) and per-
sonality disorders (i.e. 50%) being the most frequent cause of unbearable suffering 
(Thienpont et  al. 2015). The reader may consult the article by Emanuel and col-
leagues (2016) for a comprehensive review of the attitudes and end-of-life outcomes 
regarding PAD around the world.
The first Belgian case referred to the public prosecutor occurred in 2015 (i.e. phy-
sician Marc Van Hoey, involving a patient with untreatable depression); meanwhile, 
in the Netherlands, 75 cases have been sent to the public prosecutor between 2002 
and 2015, yet neither the Dutch or Belgian physicians have been prosecuted (Ema-
nuel et al. 2016). The great majority of cases involving PAD in patients with demen-
tia from 2007 to 2011 have involved early-stage patients who still understood their 
illness and the symptoms of loss of orientation and personality (Legemaate and Bolt 
2013). Interestingly, in cases involving an AED for patients with advanced demen-
tia, the attending physicians tend to disregard the directive and base their decisions 
on the current situation (i.e. basing their decision on the moral concept of benefi-
cence rather than the patient’s autonomy) (Hertogh et al. 2007).
2.2  Clinical considerations regarding AEDs for patients with dementia
2.2.1  Unbearable suffering in patients with dementia
Unbearable suffering is a subjective attribute of primary importance when the deci-
sion to proceed with a PAD in a patient has to be made. Furthermore, the clinical 
determination of unbearable suffering in a patient with dementia who may no longer 
be able to communicate is a complex topic. A physician must be able to interpret the 
body language and verbal responses from the patient (Legemaate and Bolt 2013). In 
advanced stages of dementia, the physician must indirectly infer the patient’s suf-
fering from behavioral cues related to loss of brain function such as loss of control, 
anxiety, mood swings, and helplessness; additionally, the patient may also suffer 
from behavioral and psychological symptoms of dementia (BPSD) and neuropsy-
chiatric symptoms (NPS), such as self-harm, stereotypic behavior, hallucinations, 
among others. A physician must act with due diligence when the patient is in the 
early stages of AD and request a PAD. In such cases, the RTEs recommend consult-
ing with at least one specialist, a neurologist, psychiatrist or geriatrician, in addition 
to the independent physician (RTE Annual Reports 2004).
The Royal Dutch Medical Association (RDMA) position paper regarding the 
role of the physician in PAD, considers that psychosocial or existential suffering is 
part of the medical domain; furthermore, the RDMA states that vulnerability (e.g. 
loss of function, loneliness, and loss of autonomy) should be factored into the PAD 
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decision-making process (Legemaate and Bolt 2013). In 2006, the RTE Annual 
Report recommended that PAD for patients with dementia should be “reserved for 
people with the unusual and painful combination of incipient dementia and very 
clear awareness of their disease” (RTE Annual Reports 2004). The committees rec-
ommend the physicians take into account the stage of the disease and other spe-
cific circumstances of the case before reaching a decision; furthermore, during the 
early stages of dementia, the treating physician should consult one or more experts 
in addition to the independent physician (RTE Annual Reports 2004). For a patient 
with dementia, the idea of consciously experiencing the unavoidable physical and 
mental decline, alongside with the fear of increasing loss of control over their men-
tal faculties and a perceived sense of dependence as humiliating, may be sufficient 
to classify the patient’s suffering as unbearable (RTE Annual Reports 2004). Some 
researchers argue that patients with dementia adjust actively to their disease through 
emotional and problem-oriented strategies (Marwijk et al. 2007). For a discussion 
about bioethical concepts and philosophical arguments regarding PAD in patients 
with dementia, the authors refer the reader to the work by de Beaufort and van de 
Vathorst (2016) for insight in the concepts of voluntariness and suffering (de Beau-
fort and van de Vathorst 2016). The RTEs recommend that the attending physician 
must be able to convey effectively in his report when notifying a PAD that the suf-
fering by the patient was unbearable (i.e. the RTEs refer to “unbearable suffering”). 
If the unbearable suffering criterion is not met during the independent physician’s 
evaluation, the RTEs recommend the attending physician should request another 
evaluation based on the estimation for further deterioration provided by the inde-
pendent physician or if the clinical picture suddenly worsens (RTE Annual Reports 
2004). For the attending physician to determine effectively if the patient requesting a 
PAD is undergoing unbearable suffering, he must be able to not only empathize with 
the patient’s situation but also with his point of view (e.g. life-history and values). 
To this extent, RTEs emphasize that the attending physician must be able to justify 
that the suffering was unbearable to that specific individual.
2.2.2  Decisional competence
According to the current legal framework in Belgium and the Netherlands, a vol-
untary and well-considered AED request drawn up in compos mentis represents the 
patient’s wishes in the case where the patient is not able to give his consent for the 
PAD. However, the due care criterion stipulating unbearable suffering with no pros-
pect of improvement remains fully applicable (RTE Annual Reports 2004). Two 
types of AED based on the future patient’s treatment wishes exist. The first, a nega-
tive directive, where treatments are withheld in specific circumstances; secondly, a 
positive directive, describing the treatments or actions that the patient would like to 
be carried out in certain conditions (Hertogh et al. 2007). While negative advance 
directives are binding according to the Dutch Medical Treatment Act, positive 
advance directives cannot be imposed on the attending physician (Hertogh et  al. 
2007). Clinical assessment of competency can be comprised of a detailed and com-
prehensive interview, a targeted neuropsychological evaluation, functional ability 
assessment, and a review of the legal standards (Moberg and Rick 2008). Usually, 
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this assessment of the patient’s decision-making capacity is an implicit part of the 
physician–patient interaction and made without the patient’s awareness (Appelbaum 
and Grisso 1988). Optimally, the patient and physician should have a professional 
but close relationship, one that can only be attained throughout the years of per-
sonal interaction. Capacity may be defined as a threshold requirement for a person 
to make an autonomous decision (Moye et al. 2013). While “capacity” refers to a 
clinical concept determined by a physician or health professional (Moye et al. 2013; 
Jacoby and Steer 2007), “competency” alludes to the ability of an individual to make 
decisions and is assessed by a legal professional (Moberg and Kniele 2006). The 
concept of competence alludes to four abilities: (1) ability to communicate choices; 
(2) understanding relevant information; (3) appreciating the situation and its con-
sequences; (4) manipulating information rationally (Appelbaum and Grisso 1988). 
Evaluation of treatment consent capacity is relevant to the decision-making process 
regarding a PAD request, while evaluation of testamentary capacity is appropriate if 
the patient desires to retract an AED. The ideal assessment of testamentary capac-
ity should include “a general psychiatric evaluation, a clinical interview with [the] 
observation of [the] patient’s functional abilities, a set of neuropsychological tests, 
an evaluation of the patient’s functional abilities, and the consideration of the cur-
rent legal framework” (Voskou et al. 2018). Patients with dementia may be impaired 
in their capacity to consent to medical treatment abilities; furthermore, as demen-
tia progresses, so does the consent impairment (Moye and Marson 2007). While 
decision-making abilities vary across individuals, competent individuals must pos-
sess the ability to choose independently, understanding the important information 
relevant to their choice (Dresser 2017). The nature of the request for PAD or AED 
is voluntary, and be carefully considered by the patient (RTE Annual Reports 2004). 
Patients seeking PAD must understand the range of patients’ experiences with 
dementia (Dresser 2017).
2.2.3  Awareness of memory deficits
Anosognosia is the lack of awareness of motor, visual or cognitive deficits in patients 
with neurological diseases (Langer and Levine 2014) and involves complete loss of 
knowledge of one’s impaired neurological or neuropsychological functions (Priga-
tano 2014). Many models of awareness have been developed to explain anosognosia, 
Cognitive Awareness Model (CAM) (Morris and Mograbi 2013), Autobiographical 
Memory in Alzheimer’s disease (AMAD) (Haj et al. 2015), and Feeling of Know-
ing (FOK) (Cosentino and Stern 2005; Schnyer et  al. 2004) among others, yield-
ing many approaches and perspectives regarding the unawareness of memory deficit 
phenomenon. Interestingly, clinical data associate anosognosia to different demen-
tias, eventually exhibited by nearly all persons with dementia (Wilson et al. 2016).
The validity of AED in patients with advanced dementia has been questioned since 
many patients at this stage present anosognosia and may not meet the unbearable suf-
fering requirement of the due care criteria (Hertogh et al. 2007; Hertogh 2009); none-
theless, suffering in AD is a complex physiological and psychological phenomenon. 
The degree of awareness of memory deficits in AD is associated with depressed mood, 
as increased awareness is correlated to increased depressive symptoms (Cines et  al. 
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2015). Patients with dementia may suppress their suffering by utilizing emotion-ori-
ented coping mechanisms; however, depression and not awareness of memory deficits 
appears to be the key driver of quality of life (Boer et  al. 2007). The first case of a 
PAD case involving a dementia patient reported in an annual report by the RTE (RTE 
Annual Reports 2004), involved opposing views, between the treating physician and the 
independent physician, regarding the patient’s condition. Interestingly, the two general 
practitioners differed in their perspectives regarding the suffering condition. While the 
treating physician argued that the patient was suffering unbearably due to his depend-
ence on others, his loss of decorum and loss of self-respect, the independent physi-
cian, member of the Euthanasia in the Netherlands Support and Assessment Project 
(SCEN), argued that “the patient’s awareness of his shortcomings would decrease as 
his illness took its course [and] his suffering would become less unbearable over time” 
(RTE Annual Reports 2004). In this case, the independent physician assumed that the 
patient would eventually develop anosognosia and hence his suffering would become 
tolerable. This frame of thought is loosely based on the time a patient must endure for 
his awareness to deteriorate; this argument is debatable as many factors (e.g. vascular 
events, depression) can alter the time of onset of anosognosia which makes this clini-
cal entity unpredictable. To this extent, the bioethical issue regarding the time a patient 
must endure to be categorized as having unbearable suffering becomes a topic of dis-
cussion. Bolt et al., suggest that doubt about whether suffering is unbearable might be 
a factor that explains why physicians find it less conceivable to grant a PAD request 
to patients with dementia, psychiatric disorders or who are tired of living (Bolt et al. 
2015). Further complicating this landscape, the presence of anosognosia might incen-
tivize the physician who is less likely to grant a PAD to opt for non-intervention or 
refuse to complete the AED, as they might interpret that the patient is no longer suf-
fering unbearably. These same authors suggest that moral objections, not related to the 
criteria of due care, also influence the decision-making process of carrying out an AED 
in cases of advanced dementia (Bolt et  al. 2015). A patient with AD who develops 
anosognosia no longer has a clear idea of his illness, the situation that he is in, the prog-
nosis and his alternatives. In this situation, a physician evaluating this patient can no 
longer fulfill the due care criteria required to perform the PAD.
Advance directives should not only be prepared in an early stage of the AD but at 
this point, the attending physician should ascertain and document the patient’s deci-
sional competence to guarantee that the request was voluntary. While the AED must 
be updated regularly, and an update is no longer appropriate once the patient develops 
anosognosia, an update is no longer necessary and is ethically inappropriate. The AED 
should allow the attending physician to recognize the opportune timing to perform the 
PAD; additionally, in the presence of anosognosia in patients with dementia, the input 
of the primary caregiver and family members should be incorporated early in the deci-
sion-making process.
2.3  Perspectives from two societies
Only a rather small percentage of physicians (i.e. 7%) have ever performed a PAD in 
patients suffering from causes other than cancer and other severe physical diseases 
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(i.e. early-stage and advanced dementia, psychiatric disorders, and patients who is 
tired of living) in a survey among 2269 Dutch general practitioners, elderly care 
physicians and clinical specialists (Bolt et al. 2015). While most physicians in the 
Netherlands would grant a PAD request for cancer (85%) or other physical diseases 
(82%), less than half would grant a PAD request for early-stage dementia (40%), 
psychiatric diseases (34%), advanced dementia (29–33%), and patients tired of liv-
ing (27%) (Boer et al. 2007). The three most commonly referred reasons for request-
ing PAD are, pointless suffering, loss of dignity, and weakness (Jansen-van der 
Weide et al. 2005). Physicians have the right to refuse a PAD request; nonetheless, 
several cases where a physician had refused to grant a PAD have been reported and 
questioned by the media (Bolt et al. 2015). Among the reasons commonly associated 
with refused requests are, being tired of living, being a burden to their family, and 
depression (Jansen-van der Weide et  al. 2005). Furthermore, regional differences 
exist in the Netherlands but are more pronounced in Belgium. Although the province 
of North Holland, which includes Amsterdam, had the highest prevalence of PAD in 
the Netherlands, these regional differences could not be explained by demographic, 
socioeconomic, or health-related differences; consequently, more detailed research 
is needed to specify how and why the practice of PAD differs between regions in the 
Netherlands (Koopman and Putter 2016). Meanwhile, keeping in mind that under-
reporting might be an issue, regional differences in Belgium are more pronounced, 
as the Dutch-speaking region of Flanders has higher PAD reporting rates (i.e. 73% 
to 58%). Flemish physicians had a more positive attitude toward PAD (i.e. 92% to 
87% acceptance to the administration of euthanasics and 82% to 65% acceptance 
toward euthanasia as part of a good end-of-life care) and granted more PAD requests 
(i.e. 51% to 38%) compared to the French-speaking region of Wallonia (Cohen et al. 
2012).
Although contrary to public opinion, physicians incline to support PAS over 
euthanasia; surveys in the United States, Europe, and Australia consistently show 
lower support for PAD among physicians than the general public (Emanuel et  al. 
2016). Furthermore, a survey conducted in seven countries reports approval of PAS 
ranging from 30% in France to 54% in the US (Emanuel et al. 2016); meanwhile, 
among Mexican physicians, 40% agree with PAD, 44% are against it and 16% are 
undecided (Lisker et al. 2008). Dutch physicians have a favorable opinion of PAD 
(i.e. 86% acceptance rate); similarly, physicians in Belgium approve of PAD in 81% 
(Emanuel et al. 2016). Conversely, only 10% to 33% of physicians in Finland and 
the Netherlands support PAD in advanced dementia, provided an AED exists (Tom-
linson and Stott 2015). In the Netherlands, 23% to 58% of primary and secondary 
care nurses support PAD in patients with dementia (Tomlinson and Stott 2015). 
Public opinion, as well as the medical profession, are influenced by stigma gener-
ated by PAD in patients with dementia. Dementia patient caretakers holding reli-
gious views consistently report lower acceptance of PAD in dementia (Tomlinson 
and Stott 2015). An article analyzing the metaphors surrounding public and aca-
demic discourse regarding the euthanasia debate in patients with dementia states 
that this debate is morally loaded and has stigmatized AD, thus influencing peo-
ple’s opinion toward legalization of euthanasia as an end-of-life alternative (John-
stone 2013). Public and academic discourse might be an influencing factor in how 
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physicians view the term euthanasia and PAS. The psychological meaning of the 
term ‘euthanasia’ varies between medical students and physicians. At the beginning 
of their education, medical students in Mexico have ambivalent attitudes and posit 
a negative and positive psychological connotation on the term ‘euthanasia’; while 
advanced students and physicians have both positive attitudes and psychological 
meaning in regards to ‘euthanasia’ (Río and Marván 2011). Similar to the general 
population, religion skews the perspective physicians have toward PAD. Religious 
physicians in the Netherlands find it less conceivable that they would perform a 
PAD than non-religious physicians, rejecting PAD probably on the grounds of reli-
gious principles (Marwijk et  al. 2007). Correspondingly, Mexican physicians who 
are against PAD procedures based their opinion mainly on moral and religious argu-
ments (Lisker et al. 2008). Among medical students, their outlook concerning PAD 
varies depending on the type of medical school they attend, with students enrolled in 
lay institutions approving of PAD in 68% and students attending institutions with a 
religious orientation with a 33% approval rate (Loria et al. 2013).
2.3.1  A new perspective
A physician has the ethical responsibility to do no harm, primum non nocere. In 
regards to PAD in patients with dementia, this principle applies to the patient, the 
family or primary caretaker, and the physician. All three parties must be consid-
ered and included in the decision-making process of an AED. The practice guideline 
update for mild cognitive impairment (MCI), advocates for the physician to coun-
sel patients and families about long-term projects including driving safety, finances, 
estate planning, and advance directives (Petersen et al. 2017); consequently, the dis-
cussion of an AED, among other long-term planning topics, should be addressed 
in early stages of AD. The attending physician must have careful consideration of 
the patient’s receptiveness and understanding of what MCI diagnosis and prognosis 
entails. It is the opinion of the authors that the discussion about sensitive topics such 
as AED should be initiated under the patient’s terms at the MCI stage, as evidence 
received by the RTEs reveals that patients and their relatives at end stages of life at 
times feel under great pressure to produce an AED (RTE Annual Reports 2004). 
This is where geriatric assent can facilitate this conversation, given that an AED 
should reflect the patient’s long-standing values and preferences, incorporate the 
patient’s values and preferences; as well as guarantee the protection of the patient’s 
remaining autonomy.
The role of the family varies between countries and clinical settings. In the Neth-
erlands, the family of the patients requesting PAD plays an important role in the 
decision process of granting the request, as their involvement and support influence 
end-of-life clinics’ decisions to grant the request (Snijdewind et  al. 2015). In the 
United Kingdom caretakers of patients with dementia maintain that the decision 
for PAD should be autonomous; however, they consider that the decision-making 
process should be shared with the family (Tomlinson et al. 2015). The information 
provided by the family members or primary caretakers plays an important role in 
the RTE’s assessment whether the criteria of due diligence were met by the treat-
ing physician (Tomlinson et al. 2015). Family members decide to present the AED, 
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undertaking great amounts of responsibility by initiating the deliberation process; 
furthermore, this responsibility often causes moral distress (Hertogh 2009). In the 
Netherlands, AED for euthanasia is infrequently adhered to in the case of people 
with advanced dementia, having a limited role in advance care planning and end-
of-life care of people with advanced dementia (Boer et al. 2011). While in Belgium, 
Chambaere et al. report that the end-of-life decision is typically made without the 
patient’s input (i.e. only 1.2% to 6.7% of patients with dementia are involved in the 
decision making process in cases of euthanasia), involving only the physician and 
the long-term family caregivers in the decision-making process (Chambaere et  al. 
2015). Furthermore, the decision to hospitalize nursing home patients with dementia 
in Belgium follow the physician’s orders and not an AED (Houttekier et al. 2014). 
The patients’ preferences and values regarding the end-of-life, the needs of relatives 
are factors that must be considered in the shared decision-making process of estab-
lishing an AED for patients with dementia (Dees et al. 2013). In Latin America, the 
role of the family members and caretakers of the patient with dementia is of great 
importance to the end-of-life debate. With an aging population and an inadequate 
social health care system, the patient-care burden in Mexico is undertaken by the 
family of the dementia patient (Montes de Oca and Hebrero 2008). Overall, among 
Mexican families, the burden of care of a dementia patient lies upon one or two 
family members, primarily female members, which can ultimately lead to a care-
taker burnout syndrome (Montes de Oca and Hebrero 2008). In the context of Mexi-
can culture, family dynamics are important factors to be considered when making 
end-of-life decisions regarding patients with dementia. When the economic burden 
becomes an issue for the family members of the patient, geriatric assent becomes 
of paramount importance as the right balance between the patient’s wishes and 
best interest for the family must be taken into consideration. Ideally, a patient must 
express his end-of-life wishes when competent via an AED or written directive, 
making sure his family physician and family members are aware of these wishes.
2.3.2  Future perspectives in Mexico
Colombia is the only Latin American country where PAD is legal, yet only limited 
information has been reported regarding this end-of-life option. The topic of PAD 
in patients with dementia became recently a matter of public discussion in Mexico 
following the suicide of a 72-year-old man recently diagnosed with AD in January 
2018 (Zamarrón 2018). The patient left a suicide note in which he explained that 
he had decided to take his life due to his lack of desire to live with AD and to the 
absence of a legal framework allowing for PAD in dementia. Mexico has made pro-
gress legislatively in regards to end-of-life care, as the country’s capital is expected 
to submit the final version of an amendment to its federal constitution within the 
next year, which could legalize PAD under the umbrella term of a dignified death 
(i.e. “Muerte Digna”). In Mexico 56.4% of the general population favour legalis-
ing PAS, and 58.3% favour legalising euthanasia; furthermore, 71.3% of the general 
public considers that changes in the law are necessary to allow patients to have a 
say in end-of-life decisions (Derecho and a Morir con Dignidad,  2016). If support 
for the right to a dignified death in Mexico City leads to PAD being legalized, then 
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the institutions and end-of-life medical support network for adequate euthanasia and 
PAS application in Mexico should be established.
Mexico City could be inspired by the blueprint provided by the Dutch and Bel-
gian end-of-life care experience from the last 15 years. The legal framework for PAD 
should be altered regarding special cases such as patients with dementia who request 
PAD. Elaborating and updating an AED should be part of the end-of-life manage-
ment of patients requesting a PAD, serving as a mechanism to manage the cases 
where patients with AD develop anosognosia as their cognitive decline progresses. 
In addition to addressing special cases involving AEDs, the law should establish the 
institutions that regulate PAD. These institutions must provide specific education in 
PAD and palliative care measures for patients with dementia. Mexican physicians 
lack adequate training in palliative and end-of-life care (Human Rights Watch 2014); 
additionally, not enough funds in the health care system are allocated to address the 
end-of-life care needs for “all” patients. End-of-life care and more specifically death 
as a topic are not adequately included in the curriculum in medical schools in Mex-
ico. Out of 160 medical schools in Mexico, only six provide a palliative care medi-
cine course; while only two schools make such a course compulsory (Human Rights 
Watch 2014). During their medical school education, young physicians should be 
trained to have conversations with their patients regarding end-of-life care options 
and understand the importance of AEDs. Physicians must be upfront and honest 
with dementia patients regarding their functional prognosis while integrating clini-
cal outcomes such anosognosia for the patient to adequately consider all end-of-life 
options and state any desired interventions in the patient’s end-of-life directive once 
they are no longer competent. Furthermore, clinical determination of competence is 
a skill needed by a physician to adequately assess end-of-life decisions.
An important aspect leading to the success of the PAD model in the Netherlands 
is the close patient-physician relationship. This close relationship between patient 
and physician changed due to the recent implementation of end-of-life clinics in the 
Netherlands (i.e. Levenseindekliniek). Shortly we should have more information 
about how these clinics not only address the needs of end-of-life care but impact the 
importance of a close patient-physician relationship in PAD. Mexico does not have 
a health care system where the primary physician has a lasting interaction with the 
patient. For a system resembling the Dutch PAD framework to satisfactorily work 
in Mexico, reforms in the health care system must take place. According to the lat-
est national health care survey (“Encuesta Nacional de Salud y Nutrición”) in 2016, 
13.4% of the Mexican population did not have any health care; meanwhile, 22.7% 
of respondents reported having paid for medical care (Secretaría de Salud 2017). 
Although no surveys have specifically reported the proportion of the population with 
a family physician, in actuality it is hard to envision patients attending follow-up 
consultations with the same physician. These patterns of primary medical attention 
suggest that the majority of the Mexican population does not have a family physi-
cian. The unsuitable patient-physician relationship generated by the Mexican health 
care system, the limited access to palliative care medicine, and considering that half 
of the population is poor or very poor, the need of education not only to health care 
providers but society as a whole, regarding end-of-life topics, becomes increasingly 
important.
1 3
Bioethical implications of end-of-life decision-making…
3  Conclusion
To the best of our knowledge, this is the first article that addresses the clinical 
considerations regarding PAD including determination of decisional competence 
and awareness of memory deficits (i.e. anosognosia). Furthermore, we contrast 
perspectives from culturally distinct societies as it pertains to the decision-mak-
ing process in PAD for patients with dementia. Previous work regarding the role 
of AED in end-of-life decisions involving patients with dementia has revolved 
around the ethical relevance of shared understanding and reciprocity, thus creating 
a window of opportunity for shared decision-making (Hertogh 2009). Meanwhile, 
anosognosia has been proposed as a condition in the natural history of dementia 
that limits the applicability of AED, hence some have concluded that due to clini-
cal and ethical reasons, AED could never lead to a PAD in patients with advanced 
dementia (Hertogh et al. 2007). Nonetheless, after 2012 an increase in euthanasia 
reporting has occurred, with a notable increase of PAD cases involving dementia 
patients. This upward trend in reporting is a reflection of the changing attitudes 
toward the management of PAD requests by attending physicians partially result-
ing from the work of the regional committees to educate the medical profession, 
the role of end-of-life clinics, and overall increased awareness by the population. 
This work serves as an update of the recent changes regarding the outlook of end-
of-life perspectives toward PAD and AED in patients with dementia.
Countries that are on track to legalize PAD should be stimulated to use the 
knowledge attained through the 15 years of experience obtained through the Bel-
gian and Dutch model while incorporating suitable aspects from common law 
jurisdictions (i.e. United States of America and Canada) that are relevant to their 
social and cultural context. In this article, the authors provide the social and cul-
tural context that must be considered when implementing new end-of-life legisla-
tion. The example of Mexico City’s new constitution will pose new challenges 
to the health care system and society as a whole if PAD is legalized. New insti-
tutions or committees within current institutions in the health care system must 
be established to regulate the practice of PAD similarly to the Dutch and Bel-
gian model. The topic of end-of-life care including complex conditions such as 
dementia must be introduced not only into the legislative, medical and academic 
discourse but also into the public domain, as the social impact of these legisla-
tive changes can lead to erroneous interpretations. All in all, the new law will 
empower patients with the right to choose what and how much suffering they are 
willing to bear, as well as when and how this suffering will be handled.
This work attempts to provide a perspective on a clinical approach that engages 
with conditions (i.e. anosognosia) that alter the clinical presentation in patients 
ranging from cognitive complaints to overt dementia. A discussion about the clin-
ical approach for PAD in AD was elaborated in the context of two different legal 
but inherently similar bioethical frameworks. Assessment of awareness of mem-
ory deficits allows the clinician to evaluate comprehensively the course of the 
patient’s cognitive decline. Anosognosia could potentially be a clinical condition 
that deters PAD action. The patient’s loss of competence represents the breaking 
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point for the decision-making process concerning PAD in patients with dementia. 
PAD is not the moment a life is finished, it is a well-thought-out process where 
the patient and the physician together decide that the struggle against this disease 
must end. Overall, the formal request for an AED marks the beginning to this end. 
The end of a journey poised on the patient-physician bond. A physician might not 
always be capable of healing but should always be capable of comforting. It is an 
honor for a physician to be entrusted with the assistance of birth, the maintenance 
of health and the observance and assistance to provide death with dignity.
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